KR890016036A - 아스코르브산 2-포스페이트 에스테르 - Google Patents
아스코르브산 2-포스페이트 에스테르 Download PDFInfo
- Publication number
- KR890016036A KR890016036A KR1019890005460A KR890005460A KR890016036A KR 890016036 A KR890016036 A KR 890016036A KR 1019890005460 A KR1019890005460 A KR 1019890005460A KR 890005460 A KR890005460 A KR 890005460A KR 890016036 A KR890016036 A KR 890016036A
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- substituted
- hydrocarbon group
- hydrogen atom
- acyl
- Prior art date
Links
- -1 Ascorbic acid 2-phosphate ester Chemical class 0.000 title claims 5
- 150000001875 compounds Chemical class 0.000 claims 15
- 125000001931 aliphatic group Chemical group 0.000 claims 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 4
- 125000000217 alkyl group Chemical group 0.000 claims 3
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 3
- 125000004432 carbon atom Chemical group C* 0.000 claims 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 2
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 claims 2
- 241000124008 Mammalia Species 0.000 claims 2
- 125000002723 alicyclic group Chemical group 0.000 claims 2
- 125000003342 alkenyl group Chemical group 0.000 claims 2
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Natural products OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims 1
- 239000005711 Benzoic acid Substances 0.000 claims 1
- 229940072107 ascorbate Drugs 0.000 claims 1
- 235000010323 ascorbic acid Nutrition 0.000 claims 1
- 239000011668 ascorbic acid Substances 0.000 claims 1
- 235000010233 benzoic acid Nutrition 0.000 claims 1
- 235000014113 dietary fatty acids Nutrition 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 229930195729 fatty acid Natural products 0.000 claims 1
- 239000000194 fatty acid Substances 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000002950 monocyclic group Chemical group 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 125000003367 polycyclic group Chemical group 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/62—Three oxygen atoms, e.g. ascorbic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (13)
- 하기식(I)로 표시된 화합물 또는 그의염 :식중, R1은 수소원자, 카르복실산 아실 또는 치환될 수 있는 카르바모일 ; R은 치환될 수 있는 지방족 탄화수소기 또는 치환될 수 있는 지환족 탄화수소기이다.
- 제 1 항에 있어서, 지방족 탄화수소기가 치환될 수 있는 직쇄 알킬인 화합물.
- 제 2 항에 있어서, 직쇄 알킬이 치환되지 않고, 1 내지 30탄소원자를 갖는 화합물.
- 제 1 항에 있어서, 지방족 탄화수소기가 치환될 수 있는 직쇄 알케닐인 화합물.
- 제 4 항에 있어서, 직쇄 알케닐이 치환되지 않고 1 내지 4 이중 결합이 있는 5 내지 24 탄소원자를 갖는 화합물.
- 제 1 항에 있어서, 지환족 탄화수소 잔기가 치환될 수 있는 단환족 탄화수소기 또는 축합 다환족 탄화수소기인 화합물.
- 제 1 항에 있어서, 카르복실산 아실이 치환될 수 있는 C1~22지방산 아실 또는 벤조산 아실인 화합물.
- 제 1 항에 있어서, R1이 수소원자 그리고 R이 9 내지 22탄소원자의 직쇄 알킬인 화합물.
- 제 1 항에 있어서, 디소듐 2-0-(옥타데실포스포릴) 아스코르베니트인 화합물.
- 제 1 항에 있어서, 디소듐 2-0-(리노레일포스포릴) 아스코르베이트인 화합물.
- 하기식(II)의 화합물 및 하기식(III)의 화합물을 반응시키고, 가부순해함을 특징으로 하는 하기식(I)의 화합물 또는 그의 염의 제조방법.식중 R1은 수소원자, 카르복실산아실, 또는 차환될 수 있는 카르바모일이고 ; R은 치환될 수 있는 지방족 탄화 수소기 또는 치환될 수 있는 지환족 탄화수소기이며 ; R2는 히드록실 보호기, 카르복실산아실, 또는 치환될 수 있는 카르바모일기이고 ; Z1및 Z2는 각각 수소원자 또는 히드록실 보호기이며 ; X는 할로겐이다.
- 제 1 항에 따른 화합물의 효과적인 양 및 그를 위한 약학적으로 허용할 수 있는 담체, 부형제, 또는 희석제를 포함하는 약학 화합물.
- 제 1 항에 따른 화합물의 효과적인 양을 포유동물에 투약함을 특징으로 하는, 포유동물의 순화계 장애의 예방 또는 치료방법.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63-101935 | 1988-04-25 | ||
JP10193588 | 1988-04-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR890016036A true KR890016036A (ko) | 1989-11-28 |
Family
ID=14313770
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019890005460A KR890016036A (ko) | 1988-04-25 | 1989-04-25 | 아스코르브산 2-포스페이트 에스테르 |
Country Status (10)
Country | Link |
---|---|
US (1) | US4939128A (ko) |
EP (1) | EP0339486A3 (ko) |
KR (1) | KR890016036A (ko) |
CN (1) | CN1037341A (ko) |
AU (1) | AU609283B2 (ko) |
CA (1) | CA1318315C (ko) |
DK (1) | DK191589A (ko) |
HU (1) | HU204061B (ko) |
IL (1) | IL89850A0 (ko) |
RU (1) | RU1838320C (ko) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2747001B2 (ja) * | 1989-04-18 | 1998-05-06 | 昭和電工株式会社 | L―アスコルビン酸―2―リン酸エステル類の製造法 |
UA19385A1 (uk) * | 1989-04-27 | 1997-12-25 | Сендзю Фармасьютікал Ко. Лтд. | Фофоліпідhі похідhі та композиція, яка має аhтиоксидаhтhу та іhгібуючу активhість щодо пероксидів ліпідів |
US5118817A (en) * | 1989-10-31 | 1992-06-02 | Takeda Chemical Industries, Ltd. | Process for production of 2-phosphated esters of ascorbic acid |
DE4000397A1 (de) * | 1990-01-09 | 1991-07-11 | Hoechst Ag | Lipidselektive antioxidantien sowie deren herstellung und verwendung |
EP0467691A1 (en) * | 1990-07-20 | 1992-01-22 | Takeda Chemical Industries, Ltd. | Saccharoascorbic acid derivatives and their use |
JP2998287B2 (ja) * | 1991-03-13 | 2000-01-11 | 千寿製薬株式会社 | グリチルレチン酸誘導体 |
US5110950A (en) * | 1991-06-12 | 1992-05-05 | Kansas State University Research Foundation | Method of preparing 2-phosphorylated compounds of ascorbic acid |
JPH07215801A (ja) * | 1994-01-28 | 1995-08-15 | Senju Pharmaceut Co Ltd | 肺保存剤および肺保存方法 |
CA2139549A1 (en) * | 1994-01-28 | 1995-07-29 | Kazumi Ogata | Corticoid derivatives and pharmaceutical and cosmetic compositions |
JPH07330501A (ja) * | 1994-06-14 | 1995-12-19 | Senju Pharmaceut Co Ltd | 肝保存剤および肝保存方法 |
US6162450A (en) * | 1995-05-15 | 2000-12-19 | Avon Products, Inc. | Uses of ascorbyl-phosphoryl-cholesterol and compositions for practicing same |
US5866147A (en) * | 1995-05-15 | 1999-02-02 | Avon Products, Inc. | Ascorbyl-phosphoryl-cholesterol |
US5951990A (en) * | 1995-05-15 | 1999-09-14 | Avon Products, Inc. | Ascorbyl-phosphoryl-cholesterol |
US5922335A (en) * | 1995-05-15 | 1999-07-13 | Avon Products, Inc. | Uses for ascorbyl-phosphoryl-cholesterol in topical compositions |
US5607968A (en) * | 1995-06-07 | 1997-03-04 | Avon Products, Inc. | Topical alkyl-2-O-L-ascorbyl-phosphates |
DE69605556T2 (de) * | 1996-05-14 | 2000-06-15 | Avon Prod Inc | Ascorbyl-phosphorylcholesterol |
EP0875246A1 (en) * | 1997-04-04 | 1998-11-04 | Showa Denko Kabushiki Kaisha | Pharmaceutical preparation of ascorbic acid derivatives for medical treatment of cancer |
JPH10298174A (ja) * | 1997-04-30 | 1998-11-10 | Showa Denko Kk | アスコルビン酸誘導体及びそれを含有するビタミンc剤 |
US6127409A (en) * | 1997-04-30 | 2000-10-03 | Showa Denko Kabushiki Kaisha | Ascorbic acid derivative and vitamin C preparation containing the same |
JP2926046B2 (ja) * | 1997-06-04 | 1999-07-28 | 株式会社太平洋 | 水安定型l−アスコルビン酸誘導体とその製造方法及びこれを含有する美白化粧料組成物 |
EP1189924B1 (en) * | 1999-06-23 | 2004-08-18 | Forbes Medi-Tech Inc. | Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease |
ATE347895T1 (de) * | 2000-10-25 | 2007-01-15 | Forbes Medi Tech Inc | Verbindungen die ein phytosterol- und/oder ein phytostanolteil und ascorbinsäure enthalten und deren verwendung als gewichtsregulatoren |
JP4111856B2 (ja) * | 2002-04-12 | 2008-07-02 | 昭和電工株式会社 | 安定化されたアスコルビン酸誘導体 |
KR100719777B1 (ko) * | 2004-03-25 | 2007-05-18 | 도요 뷰티 가부시키가이샤 | 아스코르브산 유도체 및 미백 화장료 |
WO2005102267A1 (en) * | 2004-04-26 | 2005-11-03 | Showa Denko K.K. | Agent for skin external use containing tocopherol derivative, ascorbic acid derivative and surface active agent having lipopeptide structure |
US7871987B2 (en) * | 2004-12-16 | 2011-01-18 | Dow Corning Corporation | Ester derivatives of ascorbic and 2-keto acid saccharides |
ATE526365T1 (de) | 2004-12-23 | 2011-10-15 | Dow Corning | Vernetzbare saccharid-siloxan-zusammensetzungen und daraus gebildete netzwerke, überzüge und artikel |
WO2006127883A2 (en) * | 2005-05-23 | 2006-11-30 | Dow Corning Corporation | Personal care compositions comprising saccharide-siloxane copolymers |
EP1885939B1 (en) * | 2005-05-23 | 2010-10-27 | Dow Corning Corporation | Surface treatment compositions comprising saccharide-siloxane copolymers |
WO2007139812A2 (en) * | 2006-05-23 | 2007-12-06 | Dow Corning Corporation | Novel silicone film former for delivery of actives |
KR20100075870A (ko) * | 2007-09-28 | 2010-07-05 | 다우 코닝 코포레이션 | 아스코브산의 에스터 유도체를 함유하는 오가노실록산 |
CN103068887B (zh) | 2010-08-23 | 2015-09-09 | 道康宁公司 | 在水性环境中稳定的糖硅氧烷以及这些糖硅氧烷的制备和使用方法 |
FR2978963A1 (fr) | 2011-08-11 | 2013-02-15 | Ascorbix | Nouveaux derives des furanones et composition pharmaceutique les contenant |
EP3150067A4 (en) * | 2014-05-30 | 2017-11-08 | SBI Pharmaceuticals Co., Ltd. | Organ preservation solution |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4179445A (en) * | 1976-05-06 | 1979-12-18 | Kansas State University Research Foundation | Method of preparation of 2-phosphate esters of ascorbic acid |
JPS59219295A (ja) * | 1983-05-30 | 1984-12-10 | Senjiyu Seiyaku Kk | リン酸ジエステルまたはその塩およびそれらの製造法 |
US4590899A (en) * | 1985-05-17 | 1986-05-27 | Stanadyne, Inc. | Self-contained lash adjuster with shell mounted cartridge assembly |
ZA852614B (en) * | 1985-05-17 | 1986-10-09 | Takeda Chemical Industries, Ltd. | Ascorbic acid ethers and their production |
JPS6230791A (ja) * | 1985-08-02 | 1987-02-09 | Showa Denko Kk | L−アスコルビン酸−2−リン酸エステルの精製法 |
JPS62205091A (ja) * | 1986-03-04 | 1987-09-09 | Senjiyu Seiyaku Kk | 新規なリン酸ジエステルならびにその塩、その製造法およびそれを含有する製剤 |
-
1989
- 1989-04-05 US US07/333,234 patent/US4939128A/en not_active Expired - Fee Related
- 1989-04-05 IL IL89850A patent/IL89850A0/xx unknown
- 1989-04-18 AU AU33161/89A patent/AU609283B2/en not_active Ceased
- 1989-04-20 EP EP19890107100 patent/EP0339486A3/en not_active Withdrawn
- 1989-04-20 DK DK191589A patent/DK191589A/da not_active Application Discontinuation
- 1989-04-20 CA CA000597234A patent/CA1318315C/en not_active Expired - Fee Related
- 1989-04-24 RU SU894613930A patent/RU1838320C/ru active
- 1989-04-24 HU HU891970A patent/HU204061B/hu not_active IP Right Cessation
- 1989-04-25 CN CN89102893A patent/CN1037341A/zh active Pending
- 1989-04-25 KR KR1019890005460A patent/KR890016036A/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0339486A3 (en) | 1991-04-24 |
IL89850A0 (en) | 1989-12-15 |
HU204061B (en) | 1991-11-28 |
CN1037341A (zh) | 1989-11-22 |
DK191589A (da) | 1989-10-26 |
DK191589D0 (da) | 1989-04-20 |
AU3316189A (en) | 1989-10-26 |
RU1838320C (ru) | 1993-08-30 |
EP0339486A2 (en) | 1989-11-02 |
AU609283B2 (en) | 1991-04-26 |
HUT51279A (en) | 1990-04-28 |
US4939128A (en) | 1990-07-03 |
CA1318315C (en) | 1993-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR890016036A (ko) | 아스코르브산 2-포스페이트 에스테르 | |
KR900006318A (ko) | 피페리디닐 벤즈이미다졸 | |
KR950014073A (ko) | 이소퀴놀린 | |
KR880003893A (ko) | 에티닐페닐을 함유하고 있는 레티오익산 유도체들 | |
KR880007507A (ko) | 크로만 유도체 | |
MY106980A (en) | Heterocyclic compounds | |
KR890011592A (ko) | 기관내 허혈병의 치료용 조성물 | |
KR950702831A (ko) | 심장 보호제(cardio-protective agent) | |
KR950000663A (ko) | 트리테르펜 유도체 및 이를 함유하는 엔도텔린-수용체 길항물질 | |
KR900016098A (ko) | 카페인산의 유도체 및 이를 함유하는 약제학적 조성물 | |
KR910000713A (ko) | 크로만 유도체 | |
KR890014480A (ko) | 2-피리딜아세트산 유도체, 이의 제조방법 및 이를 함유하는 약제학적 조성물 | |
KR900700098A (ko) | 발기부전의 치료겸 진단용 플라복세이트 및 그 유도체 | |
KR900001715A (ko) | Bu-3608 유도체 | |
KR900004697A (ko) | 고콜레스테롤 혈증치료용 4,5-디아릴-2- 치환된 티오이미다졸 | |
KR830010106A (ko) | 피페라진 유도체의 제조방법 | |
KR880009934A (ko) | 피리딘-2,4-및 2,5-디카복실산 유도체, 이의 제조방법, 이의 용도 및 이들 화합물을 기본으로 하는 약제 | |
KR910002842A (ko) | 크로만 유도체 | |
KR920012008A (ko) | 페닐알킬아미노알킬 화합물과 이들의 제법 및 이 화합물들을 포함하는 약물 | |
KR850000455A (ko) | 세팔로스포린 에스테르 유도체의 제조방법 | |
ATE66920T1 (de) | Neue carbonsaeurederivate, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten. | |
KR880013562A (ko) | 7-티아프로스타글란딘e₁ 또는 그의 유도체를 함유하는 당뇨병치료 조성물 | |
KR880013896A (ko) | 벤조푸로[3,2-c]퀴놀린 화합물 | |
KR830007693A (ko) | 7-아미노 세펨 화합물을 제조하는 개량방법 | |
KR930021203A (ko) | 죽상동맥경화 치료제로서의 독사조신의 히드록실화된 대사산물 및 유도체 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
SUBM | Surrender of laid-open application requested |